I have several years of expertise in mycoplasmology. The research efforts of our team are dedicated to understanding the biology and pathogenesis of the bacteria belonging to the class Mollicutes. Our approaches combine synthetic biology tools with comparative genomics within Mollicutes and with model organisms. We also develop applied projects aiming at finding new vaccines for mycoplasma diseases. In the MycoSynVac project we are particularly involved in the development of new methods for genome engineering of Mycoplasma pneumoniae.